Nodular basal cell carcinoma in Gorlin's syndrome treated with systemic photodynamic therapy and interstitial optical

Vishal Madan1, Juliette A Loncaster, Donald Allan

  • 1Dermatology Centre, Hope Hospital, Salford, Manchester, M6 8HD, UK.

Insights

Systemic photodynamic therapy using porfimer sodium effectively treated nodular basal cell carcinomas in Gorlin's syndrome patients resistant to other therapies. High-resolution ultrasound confirmed positive treatment outcomes.

Area of Science:

  • Dermatology
  • Oncology
  • Photomedicine

Background:

  • Nevoid basal cell carcinoma syndrome (Gorlin's syndrome) often presents with multiple basal cell carcinomas.
  • Treatment resistance is a significant challenge in managing these complex cases.

Observation:

  • Two patients with Gorlin's syndrome and treatment-resistant nodular basal cell carcinomas were studied.
  • Systemic porfimer sodium-based photodynamic therapy (PDT) with interstitial optical diffuser fibers was administered.

Findings:

  • Clinical evaluation indicated a good response to the photodynamic therapy.
  • High-resolution ultrasound (20-MHz) corroborated the positive treatment effects.

Implications:

  • Systemic PDT offers a promising therapeutic option for recalcitrant basal cell carcinomas in Gorlin's syndrome.
  • This approach may improve management strategies for rare genetic cancer predisposition syndromes.

Related Concept Videos